Article
Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research - 1 Apr 2017
Whyte Michael P
Abstract excerpt
Hypophosphatasia (HPP) is caused by loss-of-function mutation(s) of the gene that encodes the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP). Autosomal inheritance (dominant or recessive) from among more than 300 predominantly missense defects of TNSALP (ALPL) explains HPP's broad-ranging severity, the greatest of all skeletal diseases. In health, TNSALP is linked to cell surfaces and richly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
